Medicare's AI Prior-Authorization Pilot Faces Scrutiny: New Documents Reveal Systemic Flaws, Delays, and Provider Frustration

Newly released documents reveal significant operational failures in Medicare’s high-profile AI-powered prior-authorization pilot, launched in early 2024 under the oversight of CMS Administrator Chiquita Brooks-LaSure. The initiative, designed to streamline approvals for medical treatments using artificial intelligence, has instead triggered widespread delays, with over 15% of claims experiencing processing times exceeding 72 hours—well beyond the promised 24-hour turnaround. Clinicians across states including California, Texas, and Florida report that the system frequently misclassifies complex cases, leading to denials of essential care, such as cancer therapies and mental health services. Critics point to the rushed rollout, which bypassed key stakeholder consultations and failed to integrate feedback from physicians and health IT experts. The pilot, managed by a consortium of tech firms including IBM Watson Health and Cerner, was intended to reduce administrative burden and improve patient access. However, internal CMS reviews cited in the documents show that only 63% of AI-generated decisions were accurate on first review, raising concerns about algorithmic bias and clinical reliability. These findings come amid growing pressure from the American Medical Association and the Federation of State Medical Boards, which have called for greater transparency and independent audits. Why it matters: As federal agencies like the FDA and ONC explore broader digital health regulations, this pilot serves as a cautionary tale about deploying AI at scale without rigorous testing and provider input. The outcome could shape future policy on automated healthcare decision-making. Moving forward, CMS is expected to revise the program by Q3 2024, but trust in government-led AI innovation remains fragile.